Bluejay Diagnostics (BJDX) Gains from Investment Securities (2020 - 2026)
Bluejay Diagnostics' (BJDX) quarterly Gains from Investment Securities came in at $5.0 in Q1 2026, down 93.06% year-on-year from $72.0 in Q1 2025, and up 100.61% quarter-over-quarter from -$822.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has disclosed Gains from Investment Securities across 7 years of filings, most recently posting $5.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $5.0, down 93.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 (down 93.06% YoY), and the FY2025 annual result was $5.0, down 72.22% from the prior year.
- Gains from Investment Securities came in at $5.0 for Q1 2026 at Bluejay Diagnostics, up from -$822.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $35858.0 in Q2 2023 to a low of -$12597.0 in Q4 2022.
- The 5-year median for Gains from Investment Securities is $72.0 (2025), against an average of $5176.3.
- Across the five-year window, Gains from Investment Securities sank 193.15% in 2022 and surged 1783.82% in 2024, its largest moves.
- Bluejay Diagnostics' Gains from Investment Securities stood at -$12597.0 in 2022, then surged by 127.92% to $3517.0 in 2023, then surged by 231.5% to $11659.0 in 2024, then tumbled by 107.05% to -$822.0 in 2025, then soared by 100.61% to $5.0 in 2026.
- The last three Gains from Investment Securities figures came in at $5.0 (Q1 2026), -$822.0 (Q4 2025), and $32.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 |
| Mar 31, 2026 | 5.00 |
| Dec 31, 2025 | -822.00 |
| Dec 31, 2025 | -822.00 |
| Sep 30, 2025 | 32.00 |
| Sep 30, 2025 | 32.00 |
| Jun 30, 2025 | 43.00 |
| Jun 30, 2025 | 43.00 |
| Mar 31, 2025 | 72.00 |
| Mar 31, 2025 | 72.00 |
| Dec 31, 2024 | 11,659.00 |
| Dec 31, 2024 | 11,659.00 |
| Sep 30, 2024 | 5,047.00 |
| Sep 30, 2024 | 5,047.00 |
| Jun 30, 2024 | 3,721.00 |
| Jun 30, 2024 | 3,721.00 |
| Mar 31, 2024 | 29,770.00 |
| Mar 31, 2024 | 29,770.00 |
| Dec 31, 2023 | 3,517.00 |
| Dec 31, 2023 | 3,517.00 |